Tags » Biosciences

Forty years of immunology research at ILRI: An impact narrative

Since 1973, veterinary immunology has been a key aspect of research at ILRI and its predecessor, the International Laboratory for Research on Animal Diseases (ILRAD). 115 more words

Research

The global impact of ILRI’s epidemiology expertise: An impact narrative

Veterinary epidemiology was first taken up by the International Laboratory on Research on Animal Diseases (ILRAD), ILRI’s predecessor, in 1987 and initially  focussed on justifying vaccine development for East Coast fever (ECF) and trypanosomiasis. 128 more words

Research

Phd Research Fellow in Biology, Paleogenomics and Ancient DNA for Study in University of Oslo, Norway

If you would like to study in University of Oslo, Norway and pursue Full Time Phd Research Program in Biosciences you can avail Phd Research Fellow in Biology, Paleogenomics and Ancient DNA which is being offered by University of Oslo. 15 more words

Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax(TM)-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses

- Funding to support GMP manufacture of VesiculoVax(TM)-vectored vaccines for Zaire-Ebola virus, Sudan-Ebola virus, and Angola-Marburg virus that will be blended into a single formulation; rapid follow-up Phase 1 clinical trial planned Phase 1 clinical trial of VesiculoVax(TM) Zaire-Ebola virus vaccine funded -BALTIMORE, Md., Oct. 91 more words

Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax(TM)-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses | Publicwire


Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense (DoD) through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program (MCS-JVAP), a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
http://bit.ly/10a1Nq6